These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2279092)

  • 1. [Clinical and biochemical parameters of parkinsonism induced by 1-methyl-4-phenyl-1,2,2,6-tetrahydropyridine and its methyl-phenyl and methoxy-phenyl derivatives in C57Bl/6 mice].
    Lermontova NN; Soliakov LS; Bachurin SO; Serkova TP; Petrova LN; Dranyĭ OA; Tkachenko SE; Kalashnikov VV
    Biull Eksp Biol Med; 1990 Oct; 110(10):397-9. PubMed ID: 2279092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of the capability of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and pyridine derivatives to evoke parkinsonism].
    Lermontiva NN; Soliakov LS; Bachurin SO; Tkachenko SE; Serkova TP
    Biull Eksp Biol Med; 1989 Jun; 107(6):699-701. PubMed ID: 2790166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A mouse model of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced parkinsonism: effect of norepinephrine terminal destruction].
    Nishi K; Kondo T; Narabayashi H
    No To Shinkei; 1987 Jul; 39(7):663-72. PubMed ID: 3314916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.
    Jenner P; Marsden CD
    J Neural Transm Suppl; 1986; 20():11-39. PubMed ID: 3091760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MPTP- but not methamphetamine-induced parkinsonism extends to catecholamine neurons in the gut.
    Natale G; Kastsiuchenka O; Pasquali L; Ruggieri S; Paparelli A; Fornai F
    Ann N Y Acad Sci; 2008 Oct; 1139():345-9. PubMed ID: 18991880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amine fluorescence histochemical investigation of the striatum in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine(MPTP)-induced parkinsonian mice.
    Mizukawa K; Ogawa N; Sora YH
    Res Commun Chem Pathol Pharmacol; 1988 Jan; 59(1):121-8. PubMed ID: 3258432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simple quantitative bradykinesia test in MPTP-treated mice.
    Ogawa N; Hirose Y; Ohara S; Ono T; Watanabe Y
    Res Commun Chem Pathol Pharmacol; 1985 Dec; 50(3):435-41. PubMed ID: 3878557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxins and Parkinson's disease: MPTP parkinsonism in humans and animals.
    Kopin IJ
    Adv Neurol; 1987; 45():137-44. PubMed ID: 3493621
    [No Abstract]   [Full Text] [Related]  

  • 9. The neurochemical and clinical effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in small animals.
    Donnan GA; Kaczmarczyk SJ; Solopotias T; Rowe P; Kalnins RM; Vajda FJ; Mendelsohn FA
    Clin Exp Neurol; 1986; 22():155-64. PubMed ID: 3495376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Riluzole and experimental parkinsonism: antagonism of MPTP-induced decrease in central dopamine levels in mice.
    Boireau A; Dubédat P; Bordier F; Peny C; Miquet JM; Durand G; Meunier M; Doble A
    Neuroreport; 1994 Dec; 5(18):2657-60. PubMed ID: 7696626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [MPTP (N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) and parkinsonism].
    Gao XM; Ku BS
    Sheng Li Ke Xue Jin Zhan; 1989 Apr; 20(2):161-3. PubMed ID: 2686017
    [No Abstract]   [Full Text] [Related]  

  • 12. [Intrathecal infusion of brain-derived neurotrophic factor protects nigral dopaminergic neurons from degenerative changes in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced monkey parkinsonian model].
    Takeda M
    Hokkaido Igaku Zasshi; 1995 Nov; 70(6):829-38. PubMed ID: 8582706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interference of 3-O-methyldopa with L-dopa treatment for MPTP-induced parkinsonism in mice.
    Fujitake J; Kuno S; Mizuta E
    Adv Neurol; 1990; 53():225-9. PubMed ID: 2239462
    [No Abstract]   [Full Text] [Related]  

  • 14. [Parkinsonism and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (review of the literature)].
    Atadzhanov MA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(4):117-21. PubMed ID: 1650080
    [No Abstract]   [Full Text] [Related]  

  • 15. Age-dependent effects of the 2'-methyl analog of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine: prevention by inhibitors of monoamine oxidase B.
    Finnegan KT; Irwin I; Delanney LE; Langston JW
    J Pharmacol Exp Ther; 1995 May; 273(2):716-20. PubMed ID: 7752075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Decrease in motor activity in C57Bl/6 mice as affected by lymphocytes taken from animals with Parkinsonian syndrome induced by 1,2,3,6-tetrahydropyridine (MPTP)].
    Kryzhanovskiĭ GN; Davydova TV; Fomina VG; Pletsityĭ KD; Evseev VA; Krupina NA; Kucherianu VG
    Biull Eksp Biol Med; 1994 Mar; 117(3):232-4. PubMed ID: 8204836
    [No Abstract]   [Full Text] [Related]  

  • 17. Mitochondrial and metabolic toxicity of 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine.
    Kindt MV; Heikkila RE; Nicklas WJ
    J Pharmacol Exp Ther; 1987 Sep; 242(3):858-63. PubMed ID: 3498818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MPTP treatment in mice does not transmit and cause Parkinsonian neurotoxicity in non-treated cagemates through close contact.
    Lau YS; Novikova L; Roels C
    Neurosci Res; 2005 Aug; 52(4):371-8. PubMed ID: 15936837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Swim-test as a function of motor impairment in MPTP model of Parkinson's disease: a comparative study in two mouse strains.
    Haobam R; Sindhu KM; Chandra G; Mohanakumar KP
    Behav Brain Res; 2005 Sep; 163(2):159-67. PubMed ID: 15941598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of haloperidol at a low dose on the development of experimental parkinsonian syndrome].
    Korshunov AM; Voronina TA; Churiukanov VV; Iakhno NN
    Eksp Klin Farmakol; 1995; 58(6):7-9. PubMed ID: 8704620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.